Over the course of this season, one thing has kept coming up across all the episodes - the power of big data in health tech. From its uses in the current AI revolution, to universal health records and even in new sustainable practices, the way in which huge data sets are allowing health practitioners to create new products and services is as fascinating as it is exciting.

So in this season’s final episode, we take a look at the kind of utopian world that could exist when data is harnessed properly in the entire healthcare ecosystem, and what the roadmap to getting there looks like.

Find out more on this week’s episode of Invent Health from TTP.

This Week’s Guests:

Giovanna Jaramillo-Gutierrez

Giovanna is an epidemiologist researcher and a data scientist who began work as a molecular biologist, before moving into epidemiology. She works at the intersection of epidemiology and AI and is passionate about the development of ethical, human-centered, AI-based products and services. She has worked across the globe for various international organisations including the WHO and Eticas Consulting, amongst others. Get in touch with Giovanna on LinkedIn

Anthony Sitaš

Anthony is a consultant at TTP who works across digital health strategy and design and product development partnerships. His focus lies within the areas of psychology, neuroscience, clinical decision support systems and algorithmic explainability, and he is a passionate advocate of both decentralised Healthcare and Preventative and Precision Medicine. Get in touch with Anthony on LinkedIn

The Technology Partnership is where scientists & engineers develop new products and technologies that bring innovation & value to clients.

Find out more about our work here: https://www.ttp.com/

Speed is not normally something you would associate with the highly regulated world of health tech. “Rapid” time frames tend to be in the space of 3-5 years. But the Covid panic changed this - the war footing it caused brought times down enormously. It’s something that TTP played a hand in as well with Covent, TTP’s rapid manufacture ventilator for COVID-19 patients. So what can we learn from this period to bring to normal times? How can health tech practitioners work with regulators and the NHS to ensure new innovations move from idea to impact as quickly as possible? How can we achieve truly rapid innovation?

Find out more on this week’s episode of Invent Health from TTP.

This Week’s Guests:

Dr. Edwin Stone

Dr. Edwin Stone is a consultant at TTP who now leads Cellular Origins, a TTP spin-out created to enable scalable and cost-effective manufacture of cell and gene therapies. Before this, he worked on some of the earliest EMA-approved cell therapies and has been involved in the development of over 10 novel cell therapy automation platforms. He was also closely involved in Covent, TTP’s rapid manufacture ventilator for COVID-19 patients. Connect with Edwin on LinkedIn.

Luella Trickett

With over 25 years' experience in the pharmaceutical and HealthTech industries, Luella’s career has seen her hold numerous specialist manufacturing and commercial roles, with responsibility for a range of product portfolios across the HealthTech spectrum within the UK, Europe, Middle East and Africa. In 2019 she joined the ABHI as their director of value and access, an organisation who represent and support the entire industry to stakeholders, including the government, NHS, and regulators. Connect with Luella on LinkedIn.

The Technology Partnership is where scientists & engineers develop new products and technologies that bring innovation & value to clients.

Find out more about our work here: https://www.ttp.com/

There’s a multitude of ways to treat Cardiac issues, and it’s about more than just health tech. While technologies that intervene after a cardiac event has taken place are coming on leaps and bounds - from ablation catheters to pacemakers - preventative measures are seen by many as the way forward. Whether it is improved sensing technologies, the rise of telehealth, or even promoting good lifestyle factors, stopping cardiac issues even happening in the first place is a first port of call for many clinicians. But which is more significant? What’s the way forward? And how do we keep patients with cardiac issues out of the hospital?

Find out more on this week’s episode of Invent Health from TTP.

This Week’s Guests:

Professor Stephen Leslie

Professor Stephen Leslie has been an interventional cardiologist with NHS Highland since 2006, and has research interests that include heart failure and remote and rural service provision. Alongside his clinical work, Stephen is also an honorary professor with The University of the Highlands and Islands and The University of Stirling. Connect with Stephen on LinkedIn.

Simon Calcutt

Simon has been a TTP consultant for the past 8 years, and across that time, he’s been working on medical devices from drug delivery to surgical systems and active implantable devices. His current focus is around implantable devices and utilising sensor technology for real time or near real time monitoring, enabling more personalised medicine, remote patient monitoring and improved standards of care, with cardiac health as one of his main specialities. Connect with Simon on LinkedIn.

The Technology Partnership is where scientists & engineers develop new products and technologies that bring innovation & value to clients.

Find out more about our work here: https://www.ttp.com/